Trump's Pharmaceutical Investments Surge Amid Medicare Exemptions Controversy
A report reveals that President Trump's investments in pharmaceutical companies have skyrocketed, particularly in firms benefiting from Medicare exemptions. This raises ethical concerns as the policy could lead to higher drug costs for Medicare beneficiaries.
Where it's breaking
Local coverage
Trump's Pharmaceutical Investments Surge Amid Medicare Exemptions, Democrats Claim
Trump's Drugmaker Investments Surge Amid Medicare Exemptions, Democrats Claim
Trump's Drugmaker Investments Surge Amid Medicare Exemptions, Democrats Claim
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
Trump's Investments in Drugmakers Surge Amid Medicare Exemptions Controversy
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
Trump's Drugmaker Investments Surge Amid Medicare Exemptions, Democrats Claim
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
- T2WTOP Local
- T2The Virginian-Pilot
- T2Daily Press
- T2Capital Gazette
- T2Baltimore Sun
- T3Main Line Times
- T3Daily Local News (Chester County)
- T3Delaware County Daily Times
- T3Macomb Daily
- T3Oakland Press
- T2WDIV (Local 4 / NBC Detroit)
- T2Sun Sentinel (South Florida)
- T2LA Daily News
- T2Long Beach Press-Telegram
- T2Pasadena Star-News
- T2Orange County Register
- T2San Bernardino Sun
- T2Lowell Sun
- T2Boston Herald
- T2ABC Columbia (WOLO)
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.